Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Akela Pharma Announces All-Stock Merger with Nventa Biopharmaceuticals

By Pharmaceutical Processing | March 27, 2009

MONTREAL — Akela Pharma Inc. (TSX:AKL) and Nventa Biopharmaceuticals (TSX:NVN) said Friday they have finalized a merger agreement that will create a company with a total market capitalization of $4.5 million. The companies said the merger will be implemented through an all-stock transaction that will give Nventa stockholders 0.035 Akela shares for each share they hold. Each Akela share is valued at 28.16 Nventa shares. The resulting company will continue to trade and operate under the Akela name, with Nventa holding a 30 per cent stake in the merged entity. The combined company will be led by Akela’s management team, while Nventa will be able to nominate two appointees to the board of directors. The deal, which is still subject to shareholder and regulatory approval, is slated to close in May. Nventa is a maker of drugs for viral treatments, while Akela is developing a drug designed to combat cancer pain as its lead product.

Related Articles Read More >

Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE